We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Final Guidance on PDUFA VI Explains Changes to Structure and Fee Types
Final Guidance on PDUFA VI Explains Changes to Structure and Fee Types
The FDA finalized guidance on assessing user fees under PDUFA VI — covering fiscal years 2018 through 2022 — describing the new fee structure and the types of fees organizations are responsible for under the act.